Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

medical research

Switzerland's Novartis to inject $100 million into malaria drug research

Switzerland's Novartis to inject $100 million into malaria drug research

Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement